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Histone Deacetylase 2 Is Phosphorylated, Ubiquitinated,
and Degraded by Cigarette Smoke
David Adenuga1, Hongwei Yao1, Thomas H. March2, JeanClare Seagrave2, and Irfan Rahman1
1Department of Environmental Medicine, Toxicology Training and Lung Biology and Disease Programs, University of Rochester Medical Center,
Rochester, New York; and 2Lovelace Respiratory Research Institute, Albuquerque, New Mexico
Cigarette smoke (CS)–induced lung inflammation involves the re-
duction of histone deacetylase 2 (HDAC2) abundance, which is
associated with steroid resistance in patients with chronic obstruc-
tive pulmonary disease and in individuals with severe asthma who
smoke cigarettes. However, the molecular mechanism of CS-medi-
ated reduction of HDAC2 is not clearly known. We hypothesized that
HDAC2 is phosphorylated and subsequently degraded by the pro-
teasome in vitro in macrophages (MonoMac6), human bronchial and
primary small airway epithelial cells, and in vivo in mouse lungs in
response to chronic CS exposure. Cigarette smoke extract (CSE)
exposure in MonoMac6 and in bronchial and airway epithelial cells
led to phosphorylation of HDAC2 on serine/threonine residues by
a protein kinase CK2-mediated mechanism, decreased HDAC2 ac-
tivity, and increased ubiquitin-proteasome–dependent HDAC2 deg-
radation. CK2 and proteasome inhibitors reversed CSE-mediated
HDAC2 degradation, whereas serine/threonine phosphatase inhib-
itor, okadaic acid, caused phosphorylation and subsequent ubiquiti-
nation of HDAC2. CS-induced HDAC2 phosphorylation was detected
in mouse lungs from 2 weeks to 4 months of CS exposure, and mice
showed significantly lower lung HDAC2 levels. Thus, CS-mediated
down-regulation of HDAC2 in human macrophages and lung epi-
thelial cells in vitro and in mouse lung in vivo involves the induction of
serine/threonine phosphorylation and proteasomal degradation,
which may have implications for steroid resistance and abnormal
inflammation caused by cigarette smoke.
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Cigarette smoke (CS), a complex mixture of oxidants/free
radicals and different chemical compounds that include reactive
aldehydes and semiquinones known to cause oxidative stress in
the lungs, is the primary risk factor for the pathogenesis of chronic
obstructive pulmonary disease (COPD) (1–3). It is believed that
cigarette smoking is the primary cause of steroid resistance
observed in patients with COPD and in individuals with asthma
who smoke (4). Corticosteroids suppress inflammation by gluco-
corticoid receptor recruitment of histone deacetylase 2 (HDAC2)
specifically to acetylated histones on promoters of proinflamma-
tory genes, such as IL-8 and GM-CSF (5, 6).
Histone deacetylases (HDACs) are a family of cellular
enzymes that regulate gene expression by catalyzing the removal
of acetyl groups from the lysine tails of core histones (7). HDAC2
is a class I histone deacetylase that resides almost exclusively in
the nucleus and is a critical part of co-repressor complexes
recruited to proinflammatory gene promoters by associated
proteins (7). The inability of corticosteroids to recruit HDAC2
or the presence of post-translationally modified HDAC2 may
explain the abnormal inflammatory response and ineffectiveness
of corticosteroid therapy in patients with COPD (6, 8–10). In
animal inhalation experiments, lungs of rats and different strains
of mice exposed to CS exhibit significantly decreased HDAC2
levels and activity similar to that observed in peripheral blood
mononuclear cells (PBMCs) of patients with mild to severe
asthma, alveolar macrophages of patients with COPD, and
individuals with chronic asthma who smoke (8–12). Bronchial
biopsies of patients with COPD and of individuals with asthma
who smoke exhibit decreased HDAC2 levels, which correlates
with disease severity, increased cytokine production, and corti-
costeroid insensitivity (13, 14). Several studies have suggested
that corticosteroid insensitivity is closely related to reduced levels
of HDAC2, increased post-translational modifications, and sub-
sequent degradation of HDAC2 (8–11, 15, 16). For example,
HDAC2 is modified by nitration of tyrosine and S-nitrosylation
on cysteine residues by nitric oxide/reactive nitrogen species
(RNS), formation of protein-aldehyde adducts in response to CS,
or by reactive oxygen species (ROS)/aldehydes, subsequently
leading to loss of HDAC2 activity (9, 10, 17, 18). Despite over-
whelming evidence that loss of HDAC2 by ROS/RNS/aldehyde-
mediated post-translational modifications is closely linked to
corticosteroid insensitivity, the molecular mechanism of CS-
induced degradation of HDAC2, particularly relating to kinase
signaling in vivo and in vitro, is still unclear.
Previously, it has been shown that phosphorylation plays an
important role in regulating HDAC2 trans-repression ability,
enzymatic activity, and levels (19, 20). Furthermore, basal
HDAC2 abundance in cells is controlled by the ubiquitin-
proteasome pathway (21), but no studies have been conducted
to determine whether a phosphorylation-ubiquitination-pro-
teasome pathway is involved in the cellular loss of HDAC2 in
response to CS, ROS/RNS, or any environmental stimuli. In
the light of this, we sought to determine whether CS mediated
HDAC2 degradation by phosphorylation on serine/threonine
residues and whether this played a role in regulating the
enzymatic activity of HDAC2. Hence, we hypothesized that
CS-induced HDAC2 degradation is associated with increased
phosphorylation by kinase signaling and ubiquitin-protea-
some–dependent degradation of HDAC2 in human cells and
mouse lungs.
CLINICAL RELEVANCE
Cigarette smoke down-regulates histone deacetylase 2 by
phosphorylation and proteasomal degradation in epithelial
cells and macrophages and in mouse lung, which may have
implications for steroid resistance in patients with chronic
obstructive pulmonary disease and in individuals with se-
vere asthma who smoke cigarettes.
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Human monocyte-macrophage cells (MonoMac6) were maintained in
RPMI 1640 medium (Life Technologies, Gaithersburg, MD) supple-
mented with 10% fetal bovine serum (FBS) (HyClone Laboratories,
Logan, UT), 2 mM L-glutamine, 100 mg/ml penicillin, 100 U/ml
streptomycin, 1% nonessential amino acids, 1% sodium pyruvate,
1 mg/ml human holo-transferrin, 1 mM oxaloacetic acid, and 9 mg/ml
bovine insulin (10, 22). Cells were cultured at 378C in humidified
atmosphere under 5% CO2.
Human bronchial epithelial cells (H292) were purchased from the
American Type Tissue Culture Collection (Manassas, VA) and grown
in RPMI 1640 supplemented with 10% FBS (HyClone Laboratories),
2 mM L-glutamine, 100 mg/ml penicillin, and 100 U/ml streptomycin in
humidified atmosphere under 5% CO2 at 378C.
Human primary small airway epithelial cells (SAEC) derived from
a single healthy nonsmoker were purchased from Lonza (previously
Cambrex, Walkersville, MD) along with growth media (SAGM)
bulletKit supplemented with 52 mg bovine pituitary extract, 0.5 ng/ml
human recombinant epidermal growth factor (EGF), 0.5 mg/ml epi-
nephrine, 10 mg/ml transferrin, 5 mg/ml insulin, 0.1 ng/ml retinoic acid
(RA), 6.5 ng/ml triidothyronine, 50 mg/ml gentamicin/amphotericin B
(GA-1000), and 50 mg/ml fatty acid–free bovine serum albumin (BSA).
Cells were cultured for no more than seven passages.
Preparation of Aqueous Cigarette Smoke Extract
Research-grade cigarettes (2R4F) with a filter from the Kentucky
Tobacco Research and Development Centre at the University of
Kentucky (Lexington, KY) were used to prepare cigarette smoke extract
(CSE) by slowly bubbling smoke from one cigarette into 10 ml of RPMI
1640 with 0.5% serum at a rate of 1 cigarette/minutes according to the
Federal Trade Commission protocol, each puff of 2-second duration and
35-ml volume. pH of cigarette smoke extract was adjusted to 7.4 and
sterile-filtered through a 0.45-mm filter (25-mm acrodisc; Pall, Ann
Arbor, MI) (10, 23). Extract, defined as 10% CSE as stock solution,
was diluted to indicated concentrations and used for all experiments
within 15 minutes of preparation. Air was bubbled into 10 ml of RPMI
1640 with 0.5% serum and pH adjusted to 7.4, filtered, and used as con-
trol medium.
Treatments
MonoMac6 cells were washed with Ca21/Mg21-free PBS and seeded at
a density of 5.0 3 106 cells in 100 mm culture plates in a total volume of
7 ml RPMI 1640 containing 0.5% FBS. Cells were treated with CSE
(2.5%) or okadaic acid (40 nM and 1 mM) (Alexis Biochemicals, San
Diego, CA). For treatments with protein casein kinase (CK2) inhibitor,
4,5,6,7-tetrabromobenzotriazole (TBB), cells were pretreated with
20 mM TBB (Sigma, St. Louis, MO) for 1 or 2 hours. Cells were then
washed with sterile PBS before treatment with CSE. For treatments
with proteasome inhibitor (N-Acetyl-Leu-Leu-Nle-CHO, ALLN,
1 mM, 5 mM, or 20 mM) (Calbiochem, San Diego, CA), cells were
pretreated for 2 hours followed by exposure to CSE. SAEC were
grown in 12-well plates containing small airway growth media (SAGM)
until confluent and then treated with CSE (0.1%, 0.5%, and 1%) for
4 hours. H292 cells were seeded at a density of 2.5 3 106 cells in 60 mm
culture plates in a total volume of 4 ml RPMI 1640 containing 0.5%
FBS. Cells were treated with CSE (2.5%), washed in ice-cold sterile
Ca21/Mg21-free PBS and lysed in radioimmunoprecipitation assay
(RIPA) buffer (50 mM Tris HCl pH 7.4, 150 mM NaCl, 0.25 mM
EDTA, 5 mM NaF, 0.1% sodium deoxycholate, 1% Triton X-100); cell
extracts and cell culture media were stored at 2808C until analyzed.
Mouse CS Exposure
Male and female A/J mice (Jackson Laboratories, Bar Harbor, ME) at
8 to 10 weeks of age were exposed whole body to either filtered air
(FA) or dilute, mainstream CS from 1R3 nonfiltered research grade
cigarettes (27.1 mg total particulate matter yield per cigarette; Uni-
versity of Kentucky Tobacco Research and Development Center) for
16 weeks as described (24). For 2-, 4-, and 10-week mouse CS
exposures, the 2R4F research (R) grade filtered (F) cigarettes replaced
the 1R3 brand, as it was discontinued before the animal exposure
period was concluded. The 2R4F brand, unlike the 1R3, is filtered and
contains a lower total particulate matter content: 11.7 mg/cigarette, as
compared with 27.1 mg/cigarette for 1R3 (this is unusually higher
because of the lack of a filter). However, these seemingly apparent
differences are eliminated by adjusting mainstream CS smoke and
airflow to ensure constant particulate matter exposure of 250 mg/m3.
Mice were allowed to acclimatize to CS exposure in the first week by
exposing to 100 mg total particulate matter (TPM)/m3 followed by
exposure to 250 mg TPM/m3 for 5 days/week, 6 hours/day using either
cigarettes as described previously (24).
Lung Tissue Protein Extraction
Frozen lung tissue (100–150 mg) was homogenized in 0.5 ml of buffer
A (10 mM HEPES [pH 7.8], 10 mM KCl, 2 mM MgCl2, 1 mM
dithiothreitol, 0.1 M EDTA, 0.2 mM NaF, 0.2 mM Na orthovandate,
1% [vol/vol] Nonidet P-40, 0.4 mM phenylmethyl sulfonyl fluoride, and
1 mg/ml leupeptin) on ice for 30 minutes. Homogenates were centri-
fuged at 2,000 3 g in a bench-top centrifuge for 30 seconds at 48C to
remove cellular debris. Supernatants were then transferred to a 1.7-ml
ice-cold Eppendorf tube and centrifuged for 30 seconds at 13,0003 g at
48C; supernatant was collected as cytoplasmic extract. The pellet was
resuspended in 50 ml of buffer C (50 mM HEPES [pH 7.8], 50 mM KCl,
300 mM NaCl, 0.1 M EDTA, 1 mM dithiothreitol, 10% [vol/vol]
glycerol, 0.2 mM NaF, 0.2 mM Na orthovanadate, and 0.6 mM
phenylmethylsulfonyl fluoride) and placed on rotator in cold room
for 30 minutes, centrifuged at 13,000 3 g in an Eppendorf tube for
5 minutes, and supernatant collected as the nuclear extract and kept
frozen at –808C. Whole cell lysate was extracted from lung tissue after
homogenization in RIPA buffer (12, 25, 26).
Western Blotting
Cells were lysed in 100 ml RIPA buffer supplemented with protease
inhibitor cocktail (leupeptin, aprotinin, pepstatin, and PMSF) and
stored at 2808C. Protein estimation was performed by the bicincho-
ninic (BCA) acid method as described by the manufacturer (Pierce,
Rockford, IL). Whole cell lysates (10–20 mg) were electrophoresed on
7.5% SDS-polyacrylamide gels, electroblotted on PVDF membranes
(Millipore, Burlington, MA), blocked with 5% BSA in Tris-buffered
saline (TBS) with 0.1% Tween-20 for 1 hour. Membranes were
incubated with rabbit polyclonal anti-HDAC2 (sc-7899), goat poly-
clonal anti-HDAC1 (sc-6298), and anti-HDAC3 (sc-8138) (Santa Cruz,
Santa Cruz, CA) with a 1:1,000 dilution in 5% BSA in TBS. After
extensive washing, primary antibodies were detected with secondary
antibodies linked to horseradish peroxidase (Dako, Carpinteria,
CA) and bound complex detected with enhanced chemiluminescence
(PerkinElmer, Waltham, MA).
Immunoprecipitation
Cell lysate (200 mg protein) was incubated overnight with anti-HDAC2
(2 mg) at 48C, then immunoprecipitated with Protein G–agarose beads
for 1 hour with constant agitation. Beads were washed at least four
times with RIPA buffer, boiled for 10 minutes in 35 ml 23 sample
buffer and resolved on 7.5% SDS-polyacrylamide gel. Cell lysate
controls were used. Blots were probed with p-serine (1:1,000) and
p-threonine (1:1,000) (Cell Signaling, Boston, MA) monoclonal anti-
bodies for studies on the post-translational modification of HDAC2.
Immunocytochemistry
MonoMac6 cells treated with or without CSE were spun unto cytospin
slides, washed with ice-cold PBS, and fixed with 4% paraformaldehyde
in PBS. To detect HDAC2 localization, cells were permeabilized with
0.3% Triton X-100, blocked with 10% normal goat serum in immuno-
cytochemistry buffer (1 ml PBS, 50 ml normal goat serum, 5 mg BSA)
for 1 hour at room temperature to reduce nonspecific binding, and then
incubated with HDAC2 rabbit polyclonal antibody (1:100) overnight at
48C.
Cells were then incubated in goat anti-rabbit Alexa Fluor 594
(1:200) secondary antibody (Invitrogen, Carlsbad, CA) in immunocy-
tochemistry buffer for 1 hour at room temperature, washed in PBS, and
mounted with vectashield mounting media (Vector Laboratories,
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Burlingame, CA). Hoechst 33342 staining (1:1,000) was used to de-
lineate the nucleus.
HDAC Activity Assay
HDAC2 was immunoprecipitated from cell lysates or lung homoge-
nates (500 mg protein) as described above. Beads were washed and
incubated with 150 ml of 1 mM Color de Lys substrate (Biomol,
Plymouth Meeting, PA) for 80 minutes with rocking at 378C. Thirty-
microliter aliquots from each sample were placed in 96-well plates, and
20 ml HDAC specific buffer was added. Fifty microliters of Color de
Lys developer containing 2 mM trichostatin A (TSA) was then added
and incubated for a further 20 minutes with rocking at 378C. Color
development was monitored at 405 nm. HDAC2 activity was expressed
relative to standard curve generated from 0–500 mM Color de Lys
deacetylated standard.
Statistical Analysis
Data expressed as mean 6 SEM of triplicate experiments. Statistical
significance was calculated using one-way ANOVA with STATVIEW
software (SAS Institute, Cary, NC). NIH ImageJ software was used for
densitometry analysis (the P , 0.05 is considered to be statistically
significant).
RESULTS
Class I HDACs Are Degraded in Response to CSE Treatment
in MonoMac6 Cells
MonoMac6 cells were exposed to CSE (2.5%) for 0.5, 1, 2, 4,
and 6 hours. CSE decreased cellular HDAC1 and HDAC2
levels by 44% relative to controls as early as 1 hour after CSE
treatment and by 73% at 6 hours (Figures 1A and 1B).
Intriguingly, cellular HDAC3 was less sensitive to CSE treat-
ment than HDAC1 and HDAC2. To determine whether class I
HDAC degradation was due to decreased CSE-induced cell
viability, lactate dehydrogenase (LDH) secreted into condi-
tioned cell media was measured immediately after harvest. Cells
treated with CSE (2.5%) at 6 hours were more than 90% viable
as compared with cells treated with media alone (data not
shown). To confirm that HDAC2 degradation was a direct
consequence of CSE exposure, an optimal time point (6 h) was
selected at which significant HDAC2 degradation was observed
and MonoMac6 cells were exposed to increasing concentrations
of CSE. Increasing doses of CSE exposure induced a dose-
dependent decrease in HDAC2 levels (data not shown).
Class I HDACs are predominantly nuclear proteins (7), but
thought to be present in the cytoplasm. To determine if CSE
induced significant HDAC2 nucleocytoplasmic shuttling, Mono-
Mac6 cells were treated with CSE (2.5%) for 0.5, 1, 4, and 6
hours, cells were fixed in 4% paraformaldehyde and immuno-
stained with anti-HDAC2 antibodies to determine HDAC2
localization. Contrary to our expectations, HDAC2 did not
show any significant translocation to the cytoplasm in response
to CSE at any time points studied (Figure 1C).
CSE-Induced HDAC2 Degradation Is Associated with
Decreased Specific HDAC2 Activity in MonoMac6 Cells
To determine if CSE-induced loss of HDAC2 is associated with
a change in specific HDAC2 activity, MonoMac6 cells were
treated with CSE (2.5%) for 0.5, 1, and 2 hours and endogenous
HDAC2 was immunoprecipitated. HDAC2 activity was signif-
icantly decreased as early as 2 hours after CSE treatment (P ,
Figure 1. Cigarette smoke ex-
tract (CSE) time-dependently
caused degradation of class I
histone deacetylases (HDACs)
in MonoMac6 cells. Mono-
Mac6 cells were treated with
CSE (2.5%) for indicated time
points. Ten micrograms of
protein from whole cell ex-
tracts was electrophoresed on
SDS-7.5% polyacrylamide gel,
transferred onto PVDF mem-
branes, and immunochemi-
cally stained with HDAC1,
HDAC2, and HDAC3 antibod-
ies. (A) CSE significantly de-
creased class I HDAC levels as
early as 1 hour after CSE ex-
posure. (B) Relative density of
HDAC levels in MonoMac6
cells at various time points of
exposure to CSE. Open bars,
HDAC1; solid bars, HDAC2;
hatched bars, HDAC3. (C)
MonoMac6 cells were treated
with CSE (2.5%) for 0, 4, and
6 hours, cytospin slides were
prepared, and cells were fixed
in 4% paraformaldehyde and
immunostained with anti-
HDAC2 antibodies. DAPI stain
was used to visualize the nu-
cleus (shown by arrows). CSE
showed significant loss of
HDAC2 expression in the nucleus without any nucleo-cytoplasmic shuttling in MonoMac6 cells. Data are shown as mean 6 SEM (n 5 3).
***P , 0.001 or ###P , 0.001, significant compared with respective control treatments.
466 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL 40 2009
0.05) (Figure 2), indicating a possible role for CSE-induced
post-translational modifications.
CSE Induces HDAC2 Phosphorylation in MonoMac6 Cells
To determine whether CSE phosphorylated HDAC2, Mono-
Mac6 cells were treated with CSE (2.5%) for 0.5, 1, and 2 hours.
CSE induced the phosphorylation of HDAC2 on both serine
and threonine residues maximally at 0.5 hours, which thereafter
decreased time-dependently with CSE exposure (Figures 3A–
3C). CSE-induced HDAC2 phosphorylation was transient and
was diminished after longer than 2 hours of exposure to CSE.
Since CK2 has been implicated in hypoxia-induced HDAC2
phosphorylation (21, 27), we reasoned that CK2 inhibition with
a specific CK2 inhibitor, TBB (20 mM) (28), would attenuate
CSE-induced HDAC2 phosphorylation and degradation. TBB
significantly attenuated HDAC2 degradation in response to
CSE treatment (Figures 3D and 3E). At concentrations and
time points of TBB treatment, cells remained greater than 90%
viable as determined by trypan blue cell viability assay and
cellular morphology (data not shown), and no change in
HDAC2 relative levels compared with control was observed.
To further validate the CSE-induced phosphorylation of
HDAC2, MonoMac6 cells were treated with PP1/2A phospha-
tase inhibitor, okadaic acid, for 0.5 and 1 hour. Immunoprecip-
itated HDAC2 was then assessed for phosphorylation of serine
residues. Okadaic acid significantly increased the phosphoryla-
tion of HDAC2 on serine residues, as earlier observed with
CSE (Figure 3F, panels i and ii). HDAC2 phosphorylation in
response to okadaic acid was also diminished beyond 1 hour.
To further confirm our hypothesis, we determined if expo-
sure to okadaic acid would induce ubiquitination and degrada-
tion of HDAC2. MonoMac6 cells were treated with okadaic
acid (40 nM), at a dose that was not toxic to the cells for
24 hours (data not shown). Immunoprecipitated HDAC2 was
then assayed for the presence of ubiquitinated residues using
specific ubiquitin antisera by Western blot. Okadaic acid sig-
nificantly induced the ubiquitination of HDAC2 (Figure 3F,
panels iii and iv) and also induced the loss of nuclear HDAC2
(Figures 3G and 3H).
HDAC2 Degradation Is Ubiquitin-Proteasome Dependent
Since HDAC2 undergoes basal turnover via the proteasome
(21), we hypothesized that CSE-induced HDAC2 degradation is
proteasome dependent. To test this, MonoMac6 cells were
pretreated with the specific proteasome inhibitor, N-Acetyl-
Leu-Leu-Nle-CHO (ALLN) (1 mM and 5 mM) for 2 hours
before treatment with CSE (2.5%) for 6 hours. ALLN dose-
dependently inhibited HDAC2 degradation in response to CSE
(Figures 4A and 4B). ALLN (20 mM) did not induce cell death,
nor was HDAC2 degraded in cells treated with the compound
alone (data not shown). Since basal HDAC2 turnover was
proteasome dependent, we also expected that ALLN treatment
would inhibit both CSE-induced HDAC2 degradation and basal
turnover. To determine if CSE-induced HDAC2 degradation
was dependent on a ubiquitin-mediated pathway, endogenous
HDAC2 from MonoMac6 cells treated with CSE with or with-
out ALLN (1 mM) for 6 hours was immunoprecipitated and
assayed for the presence of ubiquitinated residues. CSE treat-
ment significantly induced the ubiquitination of HDAC2, which
was further enhanced by pretreatment with ALLN (Figures 4C
and 4D), an important mechanism required to target specific
proteins for proteasomal degradation.
CSE Time-Dependently Causes Degradation of HDAC2 in
Bronchial Epithelial Cells and Primary Small Airway
Epithelial Cells
Bronchial epithelial cells (H292) were exposed to CSE (2.5%)
for 1, 4, 12, and 24 hours and the levels of HDAC2 determined
by Western blot. While epithelial cells showed less sensitivity to
CSE as compared with MonoMac6 cells, CSE-induced HDAC2
degradation was observed as early as 4 hours after treatment
(Figure 5A, panels i and ii). To further confirm results observed
in transformed epithelial cells, we used human primary small
airway epithelial cells (SAEC) exposed to CSE (0.5% and 1%)
for 4 hours. Lower doses of CSE were used this time, since the
primary cells had been shown to be more sensitive compared
with immortalized epithelial cell lines (23). We found that CSE
decreased HDAC2 levels in a dose-dependent fashion in
primary SAEC cells, similar to our observations in bronchial
epithelial cell lines (Figure 5B, panels i and ii).
CSE Induces HDAC2 Phosphorylation in Human Bronchial
Epithelial and Small Airway Epithelial Cells
Bronchial epithelial cells (H292) were exposed to CSE (2.5%)
for 0.5, 1, 2, and 4 hours. CSE transiently induced HDAC2
serine phosphorylation with the most intense serine phosphor-
ylation observed in H292 cells as early as 0.5 to 1 hour (Figure
6A, panels i and ii). As was observed in MonoMac6 cells,
HDAC2 phosphorylation was cyclical. CSE (0.1%, 0.5%, and
1%) for 4 hours dose-dependently induced HDAC2 serine
phosphorylation in primary SAEC in a manner similar to that
in H292 cells (Figure 6B, panels i and ii). Higher doses of CSE
induced phosphorylation at earlier time-points (data not shown)
compared with lower doses used, an indication that an unknown
mechanism whereby HDAC2 is phosphorylated was being
induced by CSE in a dose-dependent manner. Treatment of
bronchial epithelial cells with CK2 inhibitor TBB (20 mM) for
1 hour completely reversed CSE-induced HDAC2 phosphory-
lation (Figures 6C and 6D).
CS Exposure Induces HDAC2 Degradation and Decreased
Activity Associated with its Phosphorylation in Mouse Lungs
CS exposure (2, 4, 10, and 16 wk) time-dependently decreased
HDAC2 levels in mouse lungs (Figures 7A and 7B). Further-
more, CS-exposed mice at 4 and 10 weeks significantly showed
Figure 2. CSE-induced HDAC2 degradation is associated with de-
creased specific HDAC2 activity in MonoMac6 cells. MonoMac6 cells
were treated with CSE (2.5%) for 0.5, 1, and 2 hours, and immuno-
precipitated HDAC2 (500 mg protein) from whole cell extracts was
assayed for HDAC2 activity with a colorimetric assay kit (Biomol) at 405
nm with Color de Lys substrate (500 mM) and expressed as deacetylated
standard using 1 to 500 mM standard curve. HeLa nuclear extract was
used as a positive control. Data are shown as mean 6 SEM (n 5 4).
*P , 0.05, significant compared with media alone control treatments.
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decreased HDAC2 activity compared with air-exposed mice
(Figure 7C). HDAC2 was phosphorylated at serine/threonine
residues in the lungs of mice exposed to CS from 2 to 16 weeks
as compared with mice exposed to filtered air alone (Figure 8).
Phosphorylation was more pronounced on serine residues
compared with threonine residues. Interestingly, HDAC2 level
was restored in lungs of mice allowed to recover in fresh filtered
air for 4 months after a 5-month chronic CS exposure (airspace
enlargement is seen), suggesting that CS-induced loss of HDAC2
is reversible (data not shown).
DISCUSSION
Smokers and patients with severe COPD, known to be un-
responsive to corticosteroid therapy, have decreased HDAC2
levels/expression and activity in alveolar macrophages and lungs
Figure 3. CSE induces HDAC2
phosphorylation via CK2 in
MonoMac6 cells. (A) Mono-
Mac6 cells were treated with
CSE (2.5%) for 0.5, 1, and
2 hours. Immunoprecipitated
HDAC2 was analyzed for phos-
phorylation of serine and thre-
onine residues using specific
phospho-serine and phospho-
threonine antibodies by SDS-
polyacrylamidegel.CSE induced
significant phosphorylation of
HDAC2 on serine and threo-
nine residues. NS, nonspecific
bands. Relative density of (B)
phospho-serine and (C) phos-
pho-threonine levels normal-
ized to immunoprecipitated
HDAC2 and expressed as fold
change relative to control. (D)
MonoMac6 cells were pre-
treated with or without CK2
inhibitor (20 mM 4,5,6,7-tetra-
bromobenzotriazole [TBB]) for
2 hours. Cells were then ex-
posed toCSE (2.5%) for6hours.
Tenmicrograms of protein from
whole cell lysates was electro-
phoresed on SDS-polyacrylamide
gel and assayed for HDAC2
levels. TBB significantly in-
hibited HDAC2 degradation in
response to CSE. (E) Relative
density of HDAC2 levels nor-
malized to b-actin. [F(i)] Mono-
Mac6 cells were treated with
phosphatase inhibitor, okadaic
acid (1 mM), for 0.5 hours.
Immunoprecipitated HDAC2
was analyzed for phosphoryla-
tion of serine residues using
specific phospho-serine anti-
body by SDS-polyacrylamide
gel. Okadaic acid significantly
induced phosphorylation of
HDAC2 on serine residues. [F(ii)]
Relative density of phospho-
serine expression normalized
to immunoprecipitated HDAC2.
[F(iii)] MonoMac6 cells were
treated with or without phos-
phatase inhibitor, okadaic acid (40 nM), for 24 hours. Immunoprecipitated HDAC2was assessed for bound ubiquitin using specific ubiquitin anti-sera.
Okadaic acid induced significant ubiquitination of HDAC2. [F(iv)] Relative density of ubiquitin levels normalized to immunoprecipitated HDAC2. (G)
MonoMac6 cells were treated with okadaic acid (1mM) for 0.5 hours, cytospin slides were prepared, and cells were fixed in 4%paraformaldehyde and
immunostainedwith anti-HDAC2 antibodies. DAPI stainwas used to visualize the nucleus (arrows). Okadaic acid showed an early and significant loss of
HDAC2 abundance in the nucleuswithout any nucleo-cytoplasmic shuttling inMonoMac6 cells. (H)MonoMac6 cells were treatedwith okadaic acid (1
mM) for 0.5 hours. Western blots for nuclear extracts showed significant decrease in HDAC2 expression. Data expressed as mean6 SEM (n5 3). **P,
0.01, ***P, 0.001 significant compared with media alone treatments or respective controls.
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(13). CSE-induced HDAC2 degradation also causes increased
global histone H4 acetylation and increased histone acetyltrans-
ferase (HAT) activity in alveolar epithelial A549 cells and
monocyte-macrophage MonoMac6 cells (10, 25, 29). Phosphor-
ylation is associated with decreased HDAC2 activity (20). We
sought to test the hypothesis that CS-induced down-regulation
of HDAC2 involves phosphorylation of HDAC2 particularly on
serine residues. Our data show that CSE caused degradation of
HDAC1, HDAC2, and HDAC3 in MonoMac6 cells and also
induced a decrease in specific HDAC2 activity. Interestingly,
HDAC3 was less sensitive to CSE exposure compared with
other class I HDACs studied, suggesting that HDAC3 may not
play so prominent a role in regulating the inflammatory re-
sponse in cells exposed to CSE. HDAC3 is also regarded as
distinct from HDAC1 and HDAC2, as it is not found in either
Sin3 or NuRD co-repressor complexes (30). While CSE treat-
ment induced degradation of HDAC1, HDAC2, and to a lesser
extent HDAC3, previously described mechanisms of degrada-
Figure 3. (continued).
Figure 4. CSE-mediated deg-
radation of HDAC2 is ubiqui-
tin-proteasome dependent in
MonoMac6 cells. (A) Mono-
Mac6 cells were pre-treated
with proteasome inhibitor N-
Acetyl-Leu- Leu-Nle-CHO (ALLN,
1 mM and 5 mM) for 2 hours,
followed by a 6-hour exposure
to CSE (2.5%). Ten micro-
grams of protein from whole
cell extracts was electrophor-
esed on SDS-7.5% polyacryl-
amide gel, transferred onto
PVDF membranes, and im-
munochemically stained with
HDAC2 antibodies. Dose-
dependent inhibition of the
proteasome significantly atten-
uated HDAC2 degradation. (B)
Relative density of HDAC2 lev-
els in MonoMac6 cells after
proteasome inhibition of CSE-
induced HDAC2 degradation
normalized to b-actin. (C)
MonoMac6 cells were pre-
treated with or without ALLN (1 mM) and then exposed to CSE (2.5%) for 6 hours. Immunoprecipitated HDAC2 was assayed for bound ubiquitin
using specific ubiquitin anti-sera. CSE induced significant increase in HDAC2 ubiquitination, which was enhanced with ALLN pretreatment. (D)
Relative density of ubiquitin expression in MonoMac6 cells after proteasome inhibition of CSE-induced HDAC2 degradation normalized to
immunoprecipitated HDAC2. Data shown as mean 6 SEM (n 5 3). ***P , 0.001, significant compared with media alone control treatments; ##P ,
0.001, significant compared with CSE1ALLN versus CSE alone.
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tion for all three histone deacetylases appear to differ markedly.
While HDAC1 has been reported to be degraded by diesel
exhaust particulate matter (DEP) (31) and TNF-a through an
IkB-kinase (IKK)2-dependent mechanism (32), HDAC2 and
HDAC3 were not affected. Valproic acid also selectively
degrades HDAC2 via the proteasome by increasing expression
of E2 ubiquitin-conjugating enzyme Ubc8 (21); surprisingly,
both HDAC1 and HDAC3 were not affected by valproic acid
treatment. This indicates the possibility of clear differences
in CSE-induced regulation of all three HDACs by multiple
complex pathways with the possibility of a greater similarity
between HDAC1 and HDAC2. However, we have primarily
focused on HDAC2, since its loss and decreased deacetylase
activity in the lung correlates strongly with disease severity in
patients with COPD (13).
Phosphorylation/dephosphorylation of proteins in eukaryotic
cells on serine, threonine, or tyrosine residues is an important
mechanism by which several cellular processes are regulated.
Phosphorylation may act as a master switch to turn on or off
certain kinases, activate enzymes, produce conformational changes
in proteins, or act as a trigger to induce proteasomal degradation
of certain proteins such as IkB-a.
HDAC2 was first discovered to be a phospho-protein using
in vitro kinase assays that suggested that protein kinase CK2 was
the major source of HDAC2 kinase (19). Tsai and Seto showed
that HDAC2 was specifically phosphorylated on serine but not on
threonine or tyrosine residues (19). Pluemsampant and col-
leagues also implicated protein kinase CK2 in hypoxia-induced
phosphorylation of serine residues on HDAC2 in tumor cells by
knocking down CK2a and CK2a9 expression, which abolished
HDAC2 phosphorylation (27). Tsai and Seto, using in vitro
techniques, determined three potential phosphorylation sites
(Ser394, Ser422, and Ser424) on HDAC2 that present within the
recognition sequences for protein kinase CK2, which has been
largely shown to be responsible for HDAC2 phosphorylation
(19). However, the physiological relevance of HDAC2 phosphor-
ylation remains largely controversial (19, 20, 27, 33). We observed
significant serine phosphorylation of HDAC2 in MonoMac6,
bronchial (H292), and small airway epithelial cells (SAEC), and
in mouse lungs both on serine and threonine residues. Phosphor-
ylation of threonine residues was, however, negligible, indicating
that while serine phosphorylation is global, phosphorylation of
threonine residues may be cell- and tissue-specific. This is
reinforced in part by a study that showed that serine residues,
but not threonine or tyrosine residues, on HDAC2 were phos-
phorylated by CK2 (19).
CSE induced the degradation of HDAC2 expression in
MonoMac6 cells as quickly as 1 hour after exposure, while
HDAC2 degradation was observed 2 weeks after CS exposure
in mouse lung tissue. Immunoprecipitated HDAC2 from lungs of
CS-exposed mice showed increased levels of serine phosphory-
lation as early as 2 weeks after CS exposure, and serine phos-
phorylation increased with increasing degradation of HDAC2 in
the lungs, suggesting a strong association between phosphoryla-
tion and CS-induced down-regulation of HDAC2. The highest
level of phosphorylation was observed in 16-week CS-exposed
groups, which also showed the highest level of HDAC2 degrada-
tion. Consistent with the other study in which basal phosphory-
lation of HDAC2 is seen (20), we also observed slight basal
phosphorylation of HDAC2 in lungs of air-exposed mice associ-
ated with increased HDAC2 levels.
While the mechanism of CS-induced HDAC2 phosphoryla-
tion remains unknown, it is possible that CS directly induces
several candidate kinases that phosphorylate HDAC2 or in-
directly acts as a protein phosphatase inhibitor. We tested both
the possibilities, first by treating MonoMac6 cells with the PP1/
2A inhibitor, okadaic acid. Okadaic acid induced HDAC2
phosphorylation on serine residues and caused loss of HDAC2
in the nucleus as early as 0.5 hours after inhibitor exposure.
These data were supported by the finding of Galasinski and
coworkers, who showed that okadaic acid exposure induced
phosphorylation of HDAC2 as observed by gel mobility re-
tardation and disruption of the HDAC co-repressor complex
(20). Another possibility of HDAC2 phosphorylation would be
by protein kinase CK2, which is known to be only kinase that
directly phosphorylates HDAC2 on three known recognition
Figure 5. CSE time-dependently caused
degradation of HDAC2 in human bron-
chial epithelial and primary small airway
epithelial cells. [A(i)] Bronchial epithelial
cells (H292) were treated with CSE
(2.5%) for 0, 1, 4, 12, and 24 hours. Ten
micrograms of protein from whole cell
extracts was electrophoresed on SDS-
7.5% polyacrylamide gel, transferred onto
PVDF membranes and immunochemically
stained with HDAC2 antibodies. CSE time-
dependently decreased HDAC2 levels in
H292 cells. [A(ii)] Relative density of
HDAC2 expression in H292 cells exposed
to CSE normalized to b-actin. [B(i)] Small
airway epithelial cells (SAEC)were exposed
to CSE (0.5% and 1%) for 4 hours. Whole
cell lysates were electrophoresed on SDS-
polyacrylamide gels and membranes im-
munochemically stained for HDAC2 ex-
pression. CSE time-dependently induced
HDAC2 degradation. [B(ii)] Relative den-
sity of HDAC2 levels in SAECs exposed to
CSE normalized to b-actin. Data shown as
mean 6 SEM (n 5 3). *P , 0.05, **P ,
0.01, ***P , 0.001 significant compared
with control treatments.
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sites (19). We tested the hypothesis that CK2 inhibitors would
attenuate CSE-induced HDAC2 phosphorylation in MonoMac6
cells as well as in epithelial cells. A specific CK2 inhibitor, TBB,
significantly reversed CSE-induced HDAC2 phosphorylation
and degradation, implicating phosphorylation as an important
step in CSE-induced HDAC2 degradation. Since phosphoryla-
tion is a reversible process, inactivation of protein phosphatases
by CSE will lead to irreversible phosphorylation of HDAC2,
and subsequent oxidative post-translational modifications will
render HDAC2 subject to proteasomal degradation (10, 16, 34).
Nevertheless, our data suggest that protein kinase CK2 is
involved in CSE-mediated phosphorylation of HDAC2, but
we cannot rule out the involvement of other potential kinases
(PI-3K and MAPK) in HDAC2 phosphorylation in these cells.
While Ser394, Ser422, and Ser424 are CK2 recognition motifs,
Ser411 is not, which may be potentially phosphorylated by PKA
and PKC (19). Oxidative stress (H2O2) has been shown to
induce the activation of PI-3K, which was associated with
reduced HDAC activity in U937 monocytic cell line (35). The
PI-3K/Akt inhibitor, LY-294002, restored oxidant-mediated
reduced HDAC2 activity, but the effect of PI-3K/Akt inhibition
on CSE-mediated phosphorylation of HDAC2 was not studied
(35). Since PI-3K and Akt are cell membrane-associated kinases
while HDAC2 is predominantly localized to the nucleus, we
speculate that any possible role for PI-3K in HDAC2 phos-
phorylation is most likely as an upstream activator of other
effector kinases. Furthermore, recent evidence indicates that
CSE induces binding of CK2a to HDAC2 (D. Adenuga and
colleagues, unpublished observation), strongly implicating
CK2a as the effector kinase responsible for HDAC2 phosphor-
ylation. While LY-294002, a nonspecific PI-3K inhibitor,
restores oxidant-mediated reduced HDAC2 activity (35), it
must be noted that it also inhibits CK2a with potency similar
to that of PI-3K (36), suggesting that its effects may not be
solely due to inhibition of PI-3K alone. It remains to be seen
whether PI-3K/Akt inhibitors can directly inhibit HDAC2
serine phosphorylation and restore steroid efficacy in vivo in
response to CS in mouse lungs. Indeed, as we found while
proofreading this article, Marwick and colleagues showed that
inhibition of PI-3K delta restored glucocorticoid function in
smoking-induced airway inflammation in mice (39). Neverthe-
less, understanding the involvement of specific kinase inhibitors
Figure 6. CSE induced CK2-
dependent HDAC2phosphorylation
in human bronchial epithelial and
small airway epithelial cells. [A(i)]
H292 cells were treated with CSE
(2.5%) for 0.5, 1, 2, and 4 hours.
Immunoprecipitated HDAC2 was
analyzed for phosphorylation of
serine residues using specific phos-
pho-serine antibodies by SDS-
polyacrylamide gel. CSE induced
significant cyclical phosphoryla-
tion of HDAC2 on serine residues
at 0.5, 1, and 4 hours. [A(ii)] Rela-
tive density of phospho-serine level
normalized to immunoprecipi-
tated HDAC2. [B(i)] SAECs were
exposed to CSE (0.1%, 0.5%, and
1%) for 4 hours. Immunoprecipi-
tated HDAC2 from whole cell
lysates was probed for phosphory-
lation of serine residues. CSE in-
duced a dose-dependent increase
in HDAC2 serine phosphorylation.
[B(ii)] Relative density of phospho-
serine level normalized to immu-
noprecipitated HDAC2. (C) H292
cells were treated with or without
specific CK2 inhibitor, TBB, for
1 hour, and cells werewashedwith
PBS and then treated with freshly
preparedCSE (2.5%) for 0.5 hours.
Immunoprecipitated HDAC2 was
assayed for phosphorylation on
serine residues. TBB significantly
inhibited CSE-induced HDAC2
phosphorylation. (D) Relative den-
sity of phospho-serine level nor-
malized to immunoprecipitated
HDAC2. Data expressed as mean 6
SEM (n 5 3). **P , 0.01, ***P ,
0.001, significant compared with
control treatments, or respective
controls. ##P , 0.01 significant
compared with CSE 1 TBB versus
CSE alone.
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will lead to the development of small molecule kinase inhib-
itors, which may restore steroid efficacy in patients with COPD
by restoring both HDAC2 activity and protein levels in the
lungs.
Basal HDAC2 turnover and valproic acid (VPA)-induced
HDAC2 degradation is mediated by the proteasome and requires
the E2 ubiquitin conjugase, Ubc8 (21). We determined that this
mechanism is involved in CSE-mediated HDAC2 degradation in
MonoMac6 cells. Our data showed that ALLN, a potent protea-
somal inhibitor, attenuated CSE-induced HDAC2 degradation.
Interestingly, treatment of MonoMac6 cells with the phosphatase
inhibitor (okadaic acid) also induced increased phosphorylation,
ubiquitination, and degradation of HDAC2. Ubc8 expression was
low in MonoMac6 cells, and no significant induction of Ubc8 was
observed in response to CSE, indicating that this pathway was not
required for both okadaic acid and CSE-induced HDAC2
degradation. Immunocytochemistry did not show any nucleo-
cytoplasmic shuttling of HDAC2, unlike class II HDACs. It is
known that 14-3-3e protein binds to phosphoserine residues of
HDAC4 and HDAC5, leading to nucleo-cytoplasmic shuttling
but not to HDAC1 or HDAC2 (37); this may possibly explain the
absence of nucleo-cytoplasmic shuttling in phosphorylated
HDAC2 unlike HDAC4 and HDAC5.
Our data suggest that both phosphorylation and dephos-
phorylation events are involved in CSE-mediated HDAC2
degradation. Hence, apart from kinase inhibitors, activation or
restoration of inactive protein phosphatases, such as the MAPK
phosphatase-1 (MKP-1), could prove a potential mechanism of
restoring HDAC2 levels/activity. The PP1/2A inhibitor, okadaic
acid, induced a very similar response to CSE exposure in cells,
and CS exposure is known to decrease expression of lung tissue
protein phosphatases such as MKP-1 in vivo (38). Hence the use
of specific proteasome inhibitors and/or MKP-1 activators to
attenuate CS-induced HDAC2 degradation with the long-term
goal of restoring steroid function in patients with COPD and in
individuals with asthma who smoke are areas for further research.
In conclusion, our data clearly show that HDAC2 is negatively
regulated by cigarette smoke via the phosphorylation-ubiquitin-
Figure 7. CS exposure caused HDAC2 degradation and
decreased activity in mouse lungs. Mice were exposed to
CS as described in MATERIALS AND METHODS. Lung tissue
(100–150 mg) was homogenized and nuclear extracts
prepared and frozen until analyzed. Five micrograms of
protein of nuclear extracts were analyzed for HDAC2
abundance on SDS-polyacrylamide gels. (A) CS time-de-
pendently decreased HDAC2 levels in mouse lungs. (B)
Relative density of HDAC2 levels normalized to b-actin.
(C) HDAC2 was immunoprecipitated and HDAC2 activity
measured by colorimetric assay kit (Biomol) using Color de
Lys substrate. Mice exposed to CS showed decreased
specific HDAC2 activity as compared with air exposed
mice. Data expressed as mean 6 SEM (n 5 4–5 mice per
group). *P , 0.05, **P , 0.01, ***P , 0.001, significant
compared with air-exposed mice.
Figure 8. CS induces HDAC2 phos-
phorylation inmouse lungs.Micewere
exposed to CS as described inMATERIALS
AND METHODS. Mouse lung tissue (100–
150 mg) was homogenized in RIPA
buffer (100ml) aswhole tissue extracts,
and HDAC2 (500 mg) was immuno-
precipitated. Phosphorylationof serine
and threonine residues was analyzed
using specific phospho-serine and
phospho-threonine antibodies on SDS-
polyacrylamide gel. (A) Mice exposed
to CS for 2, 4, 10, and 16 weeks
showed significant phosphorylation
of HDAC2 on both serine and threo-
nine residues; however, mice exposed
at 2 weeks did not show significant
phosphorylation on threonine resi-
dues. Relative density of (B) phospho-
serine and (C) phospho-threonine
HDAC2 levels normalized to immuno-
precipitated HDAC2. Data expressed
as mean 6 SEM (n 5 4–5 mice per
group). *P , 0.05, **P , 0.01, ***P ,
0.001, significant compared with air-
exposed littermates.
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proteasomal pathway. We further show that phosphorylation/
dephosphorylation of HDAC2 plays a predominant role in
regulating cellular HDAC2 abundance. These findings suggest
that small molecule kinase inhibitors and/or protein phosphatase
inducers (methylxanthines-theophylline, aminophylline and caf-
feine, polyphenolics-curcumin and catechins), targeted solely at
improving HDAC2 activity and level in smokers and patients
with COPD, may reverse steroid resistance.
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